These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Hedhli N; Lizano P; Hong C; Fritzky LF; Dhar SK; Liu H; Tian Y; Gao S; Madura K; Vatner SF; Depre C Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1385-93. PubMed ID: 18676687 [TBL] [Abstract][Full Text] [Related]
3. Proteasomal regulation of cardiac hypertrophy: is demolition necessary for building? Dickhout JG; Austin RC Circulation; 2006 Oct; 114(17):1796-8. PubMed ID: 17060395 [No Abstract] [Full Text] [Related]
4. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Depre C; Wang Q; Yan L; Hedhli N; Peter P; Chen L; Hong C; Hittinger L; Ghaleh B; Sadoshima J; Vatner DE; Vatner SF; Madura K Circulation; 2006 Oct; 114(17):1821-8. PubMed ID: 17043166 [TBL] [Abstract][Full Text] [Related]
5. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Tang M; Li J; Huang W; Su H; Liang Q; Tian Z; Horak KM; Molkentin JD; Wang X Cardiovasc Res; 2010 Dec; 88(3):424-33. PubMed ID: 20601385 [TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition in hypertrophied myocardium. Friehs I Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1373-4. PubMed ID: 18708439 [No Abstract] [Full Text] [Related]
7. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827 [TBL] [Abstract][Full Text] [Related]
8. Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22. Hedhli N; Wang L; Wang Q; Rashed E; Tian Y; Sui X; Madura K; Depre C Cardiovasc Res; 2008 Feb; 77(3):497-505. PubMed ID: 18006445 [TBL] [Abstract][Full Text] [Related]
9. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway. Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775 [TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling: UPS lost in transit. Razeghi P; Taegtmeyer H Circ Res; 2005 Nov; 97(10):964-6. PubMed ID: 16284188 [No Abstract] [Full Text] [Related]
11. The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction. Pan B; Li J; Parajuli N; Tian Z; Wu P; Lewno MT; Zou J; Wang W; Bedford L; Mayer RJ; Fang J; Liu J; Cui T; Su H; Wang X Circ Res; 2020 Jul; 127(4):502-518. PubMed ID: 32366200 [TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649 [TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Su H; Wang X Cardiovasc Res; 2010 Jan; 85(2):253-62. PubMed ID: 19696071 [TBL] [Abstract][Full Text] [Related]
14. Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP. Li N; Wang HX; Han QY; Li WJ; Zhang YL; Du J; Xia YL; Li HH J Mol Cell Cardiol; 2015 Feb; 79():303-14. PubMed ID: 25526681 [TBL] [Abstract][Full Text] [Related]
15. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Meiners S; Dreger H; Fechner M; Bieler S; Rother W; Günther C; Baumann G; Stangl V; Stangl K Hypertension; 2008 Feb; 51(2):302-8. PubMed ID: 18086945 [TBL] [Abstract][Full Text] [Related]